Titre : Déchets industriels

Déchets industriels : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Déchets industriels : Questions médicales les plus fréquentes", "headline": "Déchets industriels : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Déchets industriels : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-02", "dateModified": "2025-04-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Déchets industriels" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Déchets", "url": "https://questionsmedicales.fr/mesh/D014866", "about": { "@type": "MedicalCondition", "name": "Déchets", "code": { "@type": "MedicalCode", "code": "D014866", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.460.710" } } }, "about": { "@type": "MedicalCondition", "name": "Déchets industriels", "alternateName": "Industrial Waste", "code": { "@type": "MedicalCode", "code": "D007220", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Roman Fediuk", "url": "https://questionsmedicales.fr/author/Roman%20Fediuk", "affiliation": { "@type": "Organization", "name": "Polytechnic Institute, Far Eastern Federal University, 690922 Vladivostok, Russia." } }, { "@type": "Person", "name": "José Stênio Aragão Rebouças", "url": "https://questionsmedicales.fr/author/Jos%C3%A9%20St%C3%AAnio%20Arag%C3%A3o%20Rebou%C3%A7as", "affiliation": { "@type": "Organization", "name": "Marine Station of Aquaculture, Institute of Oceanography, Federal University of Rio Grande, Rio Grande, Brazil." } }, { "@type": "Person", "name": "Fernando Pablo Silva Oliveira", "url": "https://questionsmedicales.fr/author/Fernando%20Pablo%20Silva%20Oliveira", "affiliation": { "@type": "Organization", "name": "Marine Station of Aquaculture, Institute of Oceanography, Federal University of Rio Grande, Rio Grande, Brazil." } }, { "@type": "Person", "name": "Alan Carvalho de Sousa Araujo", "url": "https://questionsmedicales.fr/author/Alan%20Carvalho%20de%20Sousa%20Araujo", "affiliation": { "@type": "Organization", "name": "Marine Station of Aquaculture, Institute of Oceanography, Federal University of Rio Grande, Rio Grande, Brazil." } }, { "@type": "Person", "name": "Helena Leão Gouveia", "url": "https://questionsmedicales.fr/author/Helena%20Le%C3%A3o%20Gouveia", "affiliation": { "@type": "Organization", "name": "Laboratory of Food Technology, School of Chemistry and Food, Federal University of Rio Grande, Rio Grande, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial.", "datePublished": "2023-05-22", "url": "https://questionsmedicales.fr/article/37217960", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07352-7" } }, { "@type": "ScholarlyArticle", "name": "Protocol for a randomized controlled trial: exercise-priming of CBT for depression (the CBT+ trial).", "datePublished": "2024-10-07", "url": "https://questionsmedicales.fr/article/39375728", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-024-08495-x" } }, { "@type": "ScholarlyArticle", "name": "Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.", "datePublished": "2022-12-23", "url": "https://questionsmedicales.fr/article/36566693", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neuchi.2022.101403" } }, { "@type": "ScholarlyArticle", "name": "Emulating Randomized Controlled Trials with Hybrid Control Arms in Oncology: A Case Study.", "datePublished": "2023-01-22", "url": "https://questionsmedicales.fr/article/36606735", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cpt.2841" } }, { "@type": "ScholarlyArticle", "name": "Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35804404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-022-06365-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Pollution de l'environnement", "item": "https://questionsmedicales.fr/mesh/D004787" }, { "@type": "ListItem", "position": 5, "name": "Déchets", "item": "https://questionsmedicales.fr/mesh/D014866" }, { "@type": "ListItem", "position": 6, "name": "Déchets industriels", "item": "https://questionsmedicales.fr/mesh/D007220" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Déchets industriels - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Déchets industriels", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Déchets industriels", "description": "Comment identifier les déchets industriels ?\nQuels tests pour analyser les déchets ?\nQuels indicateurs de dangerosité ?\nQui effectue le diagnostic des déchets ?\nQuels documents pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Déchets industriels", "description": "Quels symptômes d'exposition aux déchets ?\nComment les déchets affectent-ils la santé ?\nQuels effets à long terme ?\nY a-t-il des symptômes psychologiques ?\nQuels groupes sont les plus touchés ?", "url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Déchets industriels", "description": "Comment prévenir l'exposition aux déchets ?\nQuelles formations pour les travailleurs ?\nComment réduire la production de déchets ?\nQuelles réglementations existent ?\nComment sensibiliser le public ?", "url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Déchets industriels", "description": "Quel traitement pour l'exposition aiguë ?\nY a-t-il des antidotes pour les toxines ?\nComment traiter les irritations cutanées ?\nQuels soins pour les troubles respiratoires ?\nComment gérer les effets à long terme ?", "url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Déchets industriels", "description": "Quelles complications peuvent survenir ?\nY a-t-il des complications environnementales ?\nComment les déchets affectent-ils la biodiversité ?\nQuelles sont les conséquences économiques ?\nY a-t-il des impacts sur la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Déchets industriels", "description": "Quels sont les principaux facteurs de risque ?\nComment l'âge influence-t-il le risque ?\nY a-t-il des risques liés à la géographie ?\nQuels comportements augmentent le risque ?\nComment les conditions de travail influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les déchets industriels ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les déchets industriels sont identifiés par leur origine, composition et propriétés dangereuses." } }, { "@type": "Question", "name": "Quels tests pour analyser les déchets ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests chimiques et biologiques sont effectués pour déterminer la toxicité et la composition." } }, { "@type": "Question", "name": "Quels indicateurs de dangerosité ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les indicateurs incluent la toxicité, la réactivité, la corrosivité et la pathogénicité." } }, { "@type": "Question", "name": "Qui effectue le diagnostic des déchets ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des experts en environnement et en gestion des déchets réalisent le diagnostic." } }, { "@type": "Question", "name": "Quels documents pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les fiches de données de sécurité et les rapports d'analyse sont essentiels." } }, { "@type": "Question", "name": "Quels symptômes d'exposition aux déchets ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des irritations cutanées, des troubles respiratoires et des nausées." } }, { "@type": "Question", "name": "Comment les déchets affectent-ils la santé ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent causer des maladies respiratoires, des cancers et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels effets à long terme ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition prolongée peut entraîner des maladies chroniques et des troubles génétiques." } }, { "@type": "Question", "name": "Y a-t-il des symptômes psychologiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'anxiété et la dépression peuvent survenir chez les personnes exposées." } }, { "@type": "Question", "name": "Quels groupes sont les plus touchés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs industriels et les communautés proches des sites de déchets sont les plus touchés." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux déchets ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité." } }, { "@type": "Question", "name": "Quelles formations pour les travailleurs ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des formations sur la gestion des déchets et la sécurité au travail sont essentielles." } }, { "@type": "Question", "name": "Comment réduire la production de déchets ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Adopter des pratiques de production durable et de recyclage pour minimiser les déchets." } }, { "@type": "Question", "name": "Quelles réglementations existent ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des lois encadrent la gestion des déchets industriels pour protéger la santé publique." } }, { "@type": "Question", "name": "Comment sensibiliser le public ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information et des ateliers peuvent sensibiliser sur les dangers des déchets." } }, { "@type": "Question", "name": "Quel traitement pour l'exposition aiguë ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'élimination de l'exposition et des soins médicaux d'urgence." } }, { "@type": "Question", "name": "Y a-t-il des antidotes pour les toxines ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains cas nécessitent des antidotes spécifiques, selon la toxine impliquée." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les irritations cutanées sont traitées par des crèmes apaisantes et des antihistaminiques." } }, { "@type": "Question", "name": "Quels soins pour les troubles respiratoires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les troubles respiratoires peuvent nécessiter des bronchodilatateurs et des corticostéroïdes." } }, { "@type": "Question", "name": "Comment gérer les effets à long terme ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et des traitements symptomatiques sont recommandés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des maladies chroniques, des cancers et des troubles neurologiques." } }, { "@type": "Question", "name": "Y a-t-il des complications environnementales ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la contamination des sols et des eaux peut avoir des effets durables sur l'écosystème." } }, { "@type": "Question", "name": "Comment les déchets affectent-ils la biodiversité ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les déchets peuvent nuire à la biodiversité en contaminant les habitats naturels." } }, { "@type": "Question", "name": "Quelles sont les conséquences économiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les coûts de nettoyage et de santé publique peuvent peser lourdement sur l'économie." } }, { "@type": "Question", "name": "Y a-t-il des impacts sur la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la pollution et les risques sanitaires peuvent diminuer la qualité de vie des populations." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent l'exposition professionnelle et la proximité des sites pollués." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants et les personnes âgées sont plus vulnérables aux effets des déchets industriels." } }, { "@type": "Question", "name": "Y a-t-il des risques liés à la géographie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, vivre près d'industries ou de décharges augmente le risque d'exposition." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements comme le non-respect des normes de sécurité augmentent le risque." } }, { "@type": "Question", "name": "Comment les conditions de travail influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des conditions de travail précaires et non sécurisées augmentent le risque d'exposition." } } ] } ] }

Sources (10000 au total)

A randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial.

Hearing loss is the third leading global cause of disability and is associated with poorer quality of life. Hearing aids are often recommended for hearing loss; however, hearing aid uptake and use rat... A multi-center, prospective, randomized patient-blind controlled trial with a pre- and post-tests design. New hearing aid users ≥ 18 years of age will be recruited from Vancouver, Canada. They will be... This trial is designed to evaluate the efficacy of one-on-one MI in improving hearing aid use in new adult users in the short and long terms. Results will contribute to the evidence on whether MI coun... ClinicalTrials.gov NCT04673565 . Registered on 17 December 2020....

Protocol for a randomized controlled trial: exercise-priming of CBT for depression (the CBT+ trial).

Depression is a leading cause of disability worldwide, and treatments could be more effective. Identifying methods to improve treatment success has the potential to reduce disease burden dramatically.... The CBT + trial will be a parallel-arm randomized controlled trial that will recruit 40 adult participants with DSM-5 diagnosed depression (verified with clinical interview) via referrals, mass emails... The novel approach of priming CBT with moderate-intensity aerobic exercise evaluated in a randomized controlled trial (CBT + trial) has the potential to demonstrate the usefulness of exercise as an au... ClinicalTrials.gov NCT06001346 . Registered on August 21, 2023....

Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.

To better understand the explanatory-pragmatic distinction in the design and interpretation of randomized controlled trials (RCTs).... We review the explanatory-pragmatic distinction in clinical trial design. We use the PRECIS-2 tool to evaluate the trial design of selected RCTs on percutaneous vertebroplasty for osteoporotic vertebr... The selection of criteria and the scoring of multiple PRECIS domains were subjective and thus debatable. The pragmascope patterns of various vertebroplasty trials were heterogeneous. Many trials had b... The results of a trial cannot be interpreted without understanding the various design choices made along the explanatory-pragmatic spectrum....

Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.

Lingual microcystic lymphatic malformations (LMLMs) are rare congenital vascular malformations presenting as clusters of cysts filled with lymph fluid or blood. Even small well-limited lesions can be ... This is a randomized, multicentric study using an individually randomized stepped-wedge design over 24 weeks to evaluate topical application of a 1 mg/mL sirolimus solution once daily, on LMLM, versus... Given the disappointing state of current treatment options in LMLMs, topical sirolimus could become firstline therapy in treating LMLMs if its efficacy and safety were to be demonstrated.... ClinicalTrials.gov NCT04128722 . Registered on 24 September 2019. EudraCT: EUCTR2019-001530-33-FR Sponsor (University Hospital Center of Tours - CHRU Tours): DR190041-TOPGUN French regulatory authorit...

Ayurveda Management of Allergic Rhinitis: Protocol for a Randomized Controlled Trial.

Allergic rhinitis (AR) is the inflammation of the membranes lining the nose due to allergen exposure and is characterized by sneezing, nasal congestion, itching of the nose, or postnasal discharge. Th... The primary aim is to assess the efficacy of Ayurvedic management for AR (or vataja pratishyaya) by comparing it to a conventional control group. The secondary aims are to determine the mean change in... This ongoing study is an open-label randomized controlled interventional trial, with a sample size of 90 both in the trial and standard control group (including dropouts, 20%), and will be carried out... As of May 2024, 72 patients have been enrolled in both groups. Data analysis should be completed by February 2025. The study will be reported following standard guidelines for reporting randomized con... The Ayurvedic approach could be an evidence-based therapeutic tactic for the management of AR.... Clinical Trials Registry India CTRI/2023/06/053395; https://tinyurl.com/564d2zz8.... DERR1-10.2196/56063....

Scandinavian trial of uncomplicated aortic dissection therapy: study protocol for a randomized controlled trial.

Contemporary management of uncomplicated type B aortic dissections (uTBAD) is based on the acuity and various morphological features. Medical therapy is mandatory, while the risks of early thoracic en... The trial is a randomized, open-label, superiority clinical trial with parallel assignment of subjects at 23 clinical sites in Denmark, Norway, Sweden, Finland, and Iceland. Eligibility includes patie... This trial will evaluate the primary question of whether early TEVAR improves survival at 5 years among uTBAD patients. Moreover, the costs and the impact on quality of life should provide sorely need... ClinicalTrials.gov NCT05215587. Registered on January 31, 2022....

Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial.

With advances in antiretroviral therapy, people with HIV (PWH) are living longer and are less likely to die from AIDS-related complications. Yet, prior research has shown that smoking is often not add... The current study is a type 1 hybrid effectiveness-implementation trial to evaluate the impact of a proactive, opt-out tobacco treatment intervention on cessation outcomes and advance understanding of... This study will examine a novel approach to optimizing tobacco treatment delivery for PWH. Integrating effectiveness and implementation results will help define best practices for engaging PWH with ev... ClinicalTrials.gov: NCT05019495 (August 24, 2021)....

Acupuncture as Adjuvant Therapy for Glaucoma: Protocol for a Randomized Controlled Trial.

Glaucoma is a chronic progressive optic neuropathy that necessitates lifelong treatment to reduce the decline of the optic nerve. Due to the extended and continuous treatments required for patients, c... The primary objective of this study is to conduct a single-center randomized control trial involving patients with glaucoma. Acupuncture will be evaluated as an adjunctive therapy. The trial aims to e... In this single-center randomized controlled trial, participants (N=50) with primary open-angle glaucoma will be randomly assigned to the treatment group, receiving ophthalmic acupuncture with "De Qi" ... Recruitment of participants for the trial commenced on June 28, 2023. A total of 10 participants have been enrolled to test the feasibility of the experiment. We anticipate that the preliminary data f... This trial uses rigorous methodology and comprehensive outcome measurements to assess the clinical efficacy of acupuncture as an adjunctive therapy for glaucoma, providing valuable insights for future... ClinicalTrials.gov NCT05753137; https://clinicaltrials.gov/study/NCT05753137.... DERR1-10.2196/57888....